EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus

Jinny L Liu, Gabrielle C Bayacal, Jerome Anthony E Alvarez iD, Lisa C Shriver-Lake iD, Ellen R Goldman, Scott N Dean iD

Antibodies · 14.05.2025 · 14 (2) · 41

DOI: 10.3390/antib14020041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibodies, online erschienen am 14.05.2025. Verfasst von Jinny L Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bio/Molecular Science and Engineering, US Naval Research Laboratory, Washington, DC 20375, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Threat Reduction Agency, Office of Naval Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Venezuelan equine encephalitis virus (VEEV) represents a significant biothreat with no FDA-approved vaccine currently available, highlighting the need for alternative therapeutic strategies. Single-domain antibodies (sdAbs) present a potential alternative to conventional antibodies, due to their small size and ability to recognize cryptic epitopes.

Methods

This research describes the development and preliminary evaluation of VEEV-binding sdAbs generated using a generative artificial intelligence (AI) platform. Using a dataset of known alphavirus-binding sdAbs, the AI model produced sequences with predicted affinity for the E2 glycoprotein of VEEV. These candidate sdAbs were expressed in a bacterial periplasmic system and purified for initial assessment.

Results

Enzyme-linked immunosorbent assays (ELISAs) indicated binding activity of the sdAbs to VEEV antigens. In vitro neutralization tests suggested inhibition of VEEV infection in cultured cells for some of the candidates.

Conclusions

This study demonstrates how generative AI can expedite antiviral therapeutic development and establishes a framework for quick responses to emerging viral threats when extensive example databases are unavailable. Additional refinement and validation of AI-generated sdAbs could establish effective VEEV therapeutics.

Schlagwörter

Stichwörter der Autor:innen

generative AInanobodiesviruses

Autor:innen und Institutionen

  • Center for Bio/Molecular Science and Engineering, US Naval Research Laboratory, Washington, DC 20375, USA.
  • Naval Research Enterprise Internship Program, US Naval Research Laboratory, Washington, DC 20375, USA.

ORCID-Profile: Jerome Anthony E Alvarez, Lisa C Shriver-Lake, Scott N Dean

Förderung

  • Defense Threat Reduction Agency
  • Office of Naval Research

Zitieren

APA

Liu, J. L., Bayacal, G. C., Alvarez, J. A. E., Shriver-Lake, L. C., Goldman, E. R., & Dean, S. N. (2025). Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus. Antibodies, 14(2), 41. https://doi.org/10.3390/antib14020041

Vancouver

Liu JL, Bayacal GC, Alvarez JAE, Shriver-Lake LC, Goldman ER, Dean SN. Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus. Antibodies. 2025;14(2):41. doi:10.3390/antib14020041

BibTeX
@article{Liu2025,
  author = {Liu, Jinny L and Bayacal, Gabrielle C and Alvarez, Jerome Anthony E and Shriver-Lake, Lisa C and Goldman, Ellen R and Dean, Scott N},
  title = {Generative Deep Learning Design of Single-Domain Antibodies Against Venezuelan Equine Encephalitis Virus},
  journal = {Antibodies},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {41},
  doi = {10.3390/antib14020041}
}
Kostenlos starten →